BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 36560704)

  • 1. EBV Association with Lymphomas and Carcinomas in the Oral Compartment.
    Ward BJH; Schaal DL; Nkadi EH; Scott RS
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus in the pathogenesis of oral cancers.
    Guidry JT; Birdwell CE; Scott RS
    Oral Dis; 2018 May; 24(4):497-508. PubMed ID: 28190296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-associated lymphoproliferative disorders.
    Grywalska E; Markowicz J; Grabarczyk P; Pasiarski M; Roliński J
    Postepy Hig Med Dosw (Online); 2013 May; 67():481-90. PubMed ID: 23752600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
    Longnecker R
    Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
    Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.
    Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS
    mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphomas of the oral soft tissues are not preferentially associated with latent or replicative Epstein-Barr virus.
    Gulley ML; Sargeant KP; Grider DJ; Eagan PA; Davey DD; Damm DD; Robinson RA; Vandersteen DP; McGuff HS; Banks PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Oct; 80(4):425-31. PubMed ID: 8521106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies.
    Gutierrez MI; Bhatia K; Magrath I
    Leuk Res; 1993 Mar; 17(3):285-9. PubMed ID: 8383779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
    Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus and nasopharyngeal carcinoma.
    Young LS; Dawson CW
    Chin J Cancer; 2014 Dec; 33(12):581-90. PubMed ID: 25418193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
    Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EVIDENCE OF EPSTEIN-BARR VIRUS ASSOCIATION WITH HEAD AND NECK CANCERS: A REVIEW.
    Prabhu SR; Wilson DF
    J Can Dent Assoc; 2016 Jan; 82():g2. PubMed ID: 27548665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus: biology and disease.
    Cruchley AT; Williams DM; Niedobitek G; Young LS
    Oral Dis; 1997 May; 3 Suppl 1():S156-63. PubMed ID: 9456681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.
    Shah KM; Young LS
    Clin Microbiol Infect; 2009 Nov; 15(11):982-8. PubMed ID: 19874382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis.
    Ali AS; Al-Shraim M; Al-Hakami AM; Jones IM
    Open Virol J; 2015; 9():7-28. PubMed ID: 26862355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein Barr virus - a tumor virus that needs cytotoxic lymphocytes to persist asymptomatically.
    Münz C
    Curr Opin Virol; 2016 Oct; 20():34-39. PubMed ID: 27591678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.
    Garcia P; Harrod A; Jha S; Jenkins J; Barnhill A; Lee H; Thompson M; Williams JP; Barefield J; Mckinnon A; Suarez P; Shah A; Lowrey AJ; Bentz GL
    Antiviral Res; 2021 Apr; 188():105038. PubMed ID: 33577806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of Epstein-Barr Virus-Mediated Oncogenesis].
    Iwakiri D
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1133-6. PubMed ID: 26489540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular detection of Epstein-Barr virus in different types of lymphoma.
    Shaklawoon K; Altagazi N; Altorjman F; Alturki A; Eltaweel M; Alqawi O
    Mol Biol Rep; 2020 Mar; 47(3):1803-1807. PubMed ID: 31993862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.